Prior To Coronavirus Pandemic, CBD Was Accelerating Mainstream Growth; Will CBD Continue To Jump When Economy Rebounds
Prior to the coronavirus pandemic, CBD was on a roll and was going mainstream: department stores, consumer magazines, coffee shops and specialty retailers were promoting CBD and consumers were seeking it in a variety of products, from oils to beverages. Now, after the crisis ends sometime later this year, will CBD’s growth continue?
The CBD market has drawn intense interest from media companies. stockmarketpress.com features specialized coverage of CBD related stocks such as CBD Unlimited, Inc. (OTC PINK: EDXC), Canopy Growth Corp. (NYSE: CGC), New Age Beverages Corp. (NASDAQ: NBEV), GW Pharmaceuticals PLC (NASDAQ: GWPH), Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT). Aurora Cannabis Inc. (NYSE:ACB) (TSX: ACB), Supreme Cannabis Co. (OTC: SPRWF) and OrganiGram Holdings Inc. (NASDAQ: OGI).
Prior To Coronavirus Pandemic, CBD Was accelerating Mainstream Growth; Will CBD Continue To Jump When Economy Rebounds
CBD was jumping prior to the coronavirus pandemic. Even as many dispensaries for CBD remain open for patients and some states deem CBD shops “essential businesses” that may remain open during shelter-in-place orders, CBD is not the mainstream business today it was just a few months ago. Before it was seen as an acceptable product to calm nerves, the subject of advertisements in widespread travel magazines, and even took front-and-center vignette status in fine department store chains, such as Dillard’s, in multiple states. Prior to coronavirus pandemic, CBD was accelerating mainstream growth; will CBD continue to jump when economy rebounds.
When the pandemic ends and the economy begins to re-open, perhaps by region or state in the U.S., how long will it take for CBD to regain its momentum as a mainstream darling for its innovative products and brands. No one knows for sure. And if projections for CBD sales to reach $22 billion by 2022 by the Brightfield Group were accurate once, how has the coronavirus interfered with CBD reaching that level now. Prior to coronavirus pandemic, CBD was accelerating mainstream growth; will CBD continue to jump when economy rebounds.
CBD Unlimited, Inc. (OTC PINK: EDXC) Reports $1+ Million Record Volume In Q2, Generates Accelerated Growth Curve Year-Over-Year
Some CBD brands are marketing, closing sales and revamping websites and product lines as if there were no real interruptions in the market. One is CBD Unlimited, Inc. (OTC PINK: EDXC). This week it reported $1+ Million record volume for its second quarter ended March 31, reflecting an accelerated growth curve year-over-year. It recorded an order of $1 million and recognized it in this quarter. In an updated interview with NASDAQ MarketSite reporter Jane King, CBD Unlimited, Inc.’s (OTC PINK: EDXC) Todd Davis, CEO, said the firm is forecast to hit its goal of placement in 20,000 stores roughly two-five months ahead of its year-end target. The interview can be seen and heard on YouTube.
CBD Unlimited, Inc. (OTC PINK: EDXC) finished last year with product placement in some 5,600 stores. The goal for the end of this year is 20,000 stores. Todd Davis, CEO of CBD Unlimited, Inc. (OTC PINK: EDXC) says the company is ahead of schedule. He said, “We’re on about 6,000 shelves now and will hit the 20,000 mark earlier than we thought. We’re on track to be getting there from two months to five months early.” He was referring to a corporate goal of reaching the 20,000 store mark by the end of this year.
CBD Unlimited, Inc. (OTC PINK: EDXC) $1+ Million Record Volume In Q2
The company announced this week that CBD Unlimited, Inc. (OTC PINK: EDXC) generated $1+ Million in record sales during the second quarter ending March 31, 2020. It announced today that the company had landed and recognized a $1 million deal in the quarter. That performance reflects an “accelerated growth curve year-over-year,” the company announced. Davis of CBD Unlimited, Inc. (OTC PINK: EDXC) said in the NASDAQ MarketSite interview on YouTube,
“We’re seeing a lot of the natural food stores, grocery chains, big box pharmacies reordering and stocking up a little bit more aggressively than they were in the fourth quarter of last year. Now we’re starting to see the restock flow, the reorder flow, and those are really good indicators for the industry.”
CBD Unlimited, Inc. (OTC PINK: EDXC) has been actively building its business this second carter, despite the challenging environment. In addition to its reported record sales for the three month period, it also:
- Acquired Kush, Inc., a New York-based entity which builds brands through e-commerce, strategic marketing and networking;
- Appointed two members to its Board: Dr. Daniel S. Brandwein, D.P.M., F.A.C.F.A.S., and Peter Governale, an alcohol/beverage marketing expert;
- Launched its first phase of product testing for its new line of Equine CBD product, TrailRMix™;
- Introduced at ECRM 2020 its new Value-line, along with CBD-infused chocolates and honey sticks
Davis said, “During this quarter, we achieved impressive sales and orders directly related to our market store expansion strategy. We forecast that CBD Unlimited will again hit its year-end goal of 20,000 stores roughly 2-5 months early.” CBD Unlimited, Inc. (OTC PINK: EDXC)
CBD Unlimited (OTC PINK: EDXC) Develops, Distributes All Natural Products Derived From Hemp
CBD Unlimited (OTC PINK: EDXC) develops and distributes all-natural CBD products derived from hemp. Its portfolio of products includes oils, capsules, topical and pet products. Phyto-Bites are soft chews for animal use designed to reduce inflammation, pain and separation-anxiety. It also has CBD products formulated for humans. The company’s CBD hemp product has premium genetics and superior quality. The extracts in its products are rich in photo-cannabinoids and terpenoids that are non-psychoactive.
CBD Unlimited, Inc. (OTC PINK: EDXC) ensures that its CBD product is monitored every step of the way: from U.S. hemp growing, processing and marketing. The consumer can be confident of the brand and investors in the company can be assured of its attention to controlling product quality, producing CBD products from hemp sourced and grown in Colorado and Kentucky under USDA and state regulations.
Source: Stock Market Press
Join Stock Market Press’ newsletter for the latest in IPO, market commentary and company profiles.
Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.
Contact:
Stock Market Press
110 Wall St.
New York, NY 10005 info@stockmarketpress.com Safe Harbor Statement:
Statements in this news release may be ”forward-looking statements.” Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.
See Stock Market Press disclaimer: https://stockmarketpress.com/disclaimer/ SOURCE: Stock Market Press
